Fuji Pharma Co., Ltd. (TYO:4554)
Japan · Delayed Price · Currency is JPY 2,526.00
+152.00 (6.40%)
At close: Mar 27, 2026
Fuji Pharma Market Cap
Fuji Pharma has a market cap or net worth of 65.94 billion as of March 27, 2026. Its market cap has increased by 97.62% in one year.
Market Cap
65.94B
Enterprise Value
93.02B
Revenue
54.57B
Ranking
n/a
PE Ratio
26.46
Stock Price
2,526.00
Market Cap Chart
Since December 21, 2005, Fuji Pharma's market cap has increased from 17.38B to 65.94B, an increase of 279.32%. That is a compound annual growth rate of 6.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 65.94B | 42.82% |
| Dec 30, 2025 | 46.17B | 18.77% |
| Dec 30, 2024 | 38.88B | -8.01% |
| Dec 29, 2023 | 42.26B | 70.05% |
| Dec 30, 2022 | 24.85B | -0.36% |
| Dec 30, 2021 | 24.94B | -35.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kissei Pharmaceutical | 194.82B |
| Kaken Pharmaceutical | 159.80B |
| Mochida Pharmaceutical | 130.46B |
| KYORIN Pharmaceutical | 95.99B |
| Zeria Pharmaceutical | 94.43B |
| ASKA Pharmaceutical Holdings | 66.28B |
| Daito Pharmaceutical | 42.70B |
| Koa Shoji Holdings | 35.04B |